Investment
Features
FeesSafety
Academy
More
Pluang+

Compare EOG Resources Inc (EOG) vs Sana Biotechnology Inc (SANA) Price & Performance

EOG Resources IncTrade
Sana Biotechnology IncTrade

Price performance (Past 24H)

Key statistics

EOG Resources Inc vs Sana Biotechnology Inc — how do they compare? EOG Resources Inc trades at $138.86 (market cap $73.22B), while Sana Biotechnology Inc trades at $3.41 (market cap $987.94M). The key difference: EOG Resources Inc is far larger — about 74.1× Sana Biotechnology Inc's market cap, and EOG Resources Inc pays a 2.97% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.

EOGSANA
Market Cap
$73.22B$987.94M
Sector
EnergyHealth
52-Week High
$149.89$5.92
52-Week Low
$101.78$2.68
Enterprise Value
$77.68B$962.13M
Dividend Yield
2.97%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

EOG Resources Inc

EOG Resources trades at $138.01, down 1.15% on the day, with a bullish technical signal from moving averages and strong analyst support. The company maintains robust profitability with a net income margin of 23.39% and has beaten earnings estimates for the last three quarters. Recent news highlights its valuation discount and operational strength, with a consensus price target of $156.40 suggesting upside potential.

The outlook for EOG is positive, driven by consistent earnings beats, solid cash flow, and a favorable analyst consensus. Key risks include oil price volatility and elevated capital expenditures. The stock presents an opportunity for growth investors seeking exposure to a high-quality energy producer trading below target prices.

Sana Biotechnology Inc

SANA Biotechnology trades at $3.45, down 3.36% today, with a bullish technical signal from moving averages and oscillators. The company shows strong analyst support with 82% buy ratings but faces significant financial challenges including negative ROE of -147.41% and consistent quarterly losses. Recent developments include positive clinical data presentations and a strategic collaboration with Mayo Clinic announced in May 2026.

While technical indicators suggest near-term upside potential and analyst sentiment remains positive, fundamental weaknesses including substantial cash burn and negative profitability present significant investment risks. The stock's outlook depends heavily on successful clinical development and future revenue generation from its engineered cell therapies.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About EOG Resources Inc

EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.

Read more on EOG

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Read more on SANA